RxDoctor Payments Data

David Vise, OD

Optometrist · Santa Fe, NMNPI 1528093622

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 31.5% of the total. Reporting peaked in 2022 at $2,950 and has fallen 82.2% since, to $525 in 2025. Among optometrist clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,774in general payments, 2019–2025

Across 125 payments — averaging $62.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Biotissue Holdings Inc.$572
  • Alcon$518
  • Sun Pharmaceutical Industries Inc.$426
  • AbbVie$325
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$3,52445%
  • Food & beverage$4,25055%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,774 in reported general payments places this provider in the 95th percentile of 228 optometrist providers in New Mexico.

See all optometrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$44,792
Medicare patients
210
Services billed
522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclosporine15$7,072
Prednisolone Acetate26$791
Latanoprost27$689
Tobramycin-DexamethasoneTobramycin/Dexamethasone13$557

Paid to pharmacies, not to this prescriber.

Other optometrist in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →